Related Experiment Video
Updated: Apr 24, 2026

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Gabapentin for the treatment of persistent hiccups
Peter Campbell1, Sharon Janak, Olga Hilas
1New York-Presbyterian Hospital, New York, New York, USA.
Objective:
To report a case of persistent hiccups successfully treated with gabapentin in an elderly male.
Setting:
An acute care unit for elders within a large teaching hospital.
Case Summary:
An 86-year-old male was admitted to the hospital for treatment of a urinary tract infection. In addition to his infection, the patient complained of bothersome hiccups with an onset several days prior to admission. He received metoclopramide for two days without improvement. Based on his medical history and a probable neurogenic etiology, gabapentin was recommended for his hiccups. Symptoms improved within several hours, with complete resolution after a dose titration to 200 mg twice daily on the second day of gabapentin treatment. The patient was ultimately discharged back to his long-term care facility, but was readmitted three days later for the treatment of pneumonia. His hiccups recurred and were treated unsuccessfully with metoclopramide in the emergency department. Gabapentin was reinitiated by the geriatric medicine team, and the patient's hiccups resolved once again.
Conclusion:
Randomized, controlled trials evaluating the use of gabapentin in the treatment of hiccups associated with neurogenic etiologies are lacking; however, case reports suggest that this agent may be an effective treatment option.
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Drugs for Treatment of Constipation-Predominant IBS
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Antiepileptic Drugs: Glutamate Antagonists
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

